Back to search
FDAFDA · Food and drugs·Recall number Z-1877-2025

BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems

Published June 4, 2025 · Recall initiated: April 30, 2025

Summary

FDA records medical device Class II recall Z-1877-2025, published June 4, 2025 and initiated April 30, 2025. Recalling firm: BioFire Diagnostics, LLC; Status: Ongoing; Reported quantity: 30 kits; Lot: Lot# 1475424/ UDI: None. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BioFire Diagnostics, LLC
Distributor
International distribution in the country of Singapore.
Lot
Lot# 1475424/ UDI: None
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BioFire Respiratory Panel 2.1 plus Kit, REF: 423740, For Filmarray systems recalled?

Yes. FDA published recall Z-1877-2025 on June 4, 2025. Reported hazard: Due to manufacturing error, respiratory panel may result in elevated control failures and/or false negative results.

What should I do if I have this product?

Voluntary: Firm initiated · Letter